pyrroles has been researched along with Affective Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castro, AA; Lapa, FR; Matheus, FC; Prediger, RD; Santos, AR; Tasca, CI; Viola, GG; Wiemes, BP | 1 |
| Chrousos, GP; Gold, PW; Rice, KC; Zoumakis, E | 1 |
1 review(s) available for pyrroles and Affective Disorders
| Article | Year |
|---|---|
Potential uses of corticotropin-releasing hormone antagonists.
Topics: Animals; Anxiety; Corticotropin-Releasing Hormone; Depression; Humans; Macaca; Mood Disorders; Neurodegenerative Diseases; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; Urocortins | 2006 |
1 other study(ies) available for pyrroles and Affective Disorders
| Article | Year |
|---|---|
Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Analysis of Variance; Animals; Antiparkinson Agents; Atorvastatin; Brain; Cognition Disorders; Cytokines; Disease Models, Animal; Food Preferences; Heptanoic Acids; Male; Maze Learning; Mood Disorders; Motor Activity; Parkinsonian Disorders; Pyrroles; Rats; Rats, Wistar; Social Behavior; Sucrose; Sweetening Agents; Swimming; Tyrosine 3-Monooxygenase | 2013 |